NLRP3 and metabolic dysfunction-associated steatotic liver disease: Therefore, BSP-1 plays a role in alleviating MASLD by preventing steatosis, inflammation, and pyroptosis, which may be relate to the inhibition of NLRP3/caspase-1/GSDMD signaling pathway (Figure 9).